Rezafungin Acetate not checked

Mundipharma Research Limited · CD101

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2 trial completes
Trials
4 active
7 in total · 5 in the EU

What this is

How it works
Echinocandin Antifungal FDA class
How it’s given
“Rezafungin for infusion. Intravenous anti fungal therapy Oral co-trimoxazole or Intravenous (IV) co-trimoxazole for infusion. Anti fungal medication”In the company’s words, NCT05835479 on ClinicalTrials.gov
Tested for
Pneumocystis Pneumonia, Chronic Pulmonary Aspergillosis
Main trialPhase 2
“This study aims to generate clinical data on the efficacy, safety, and tolerability of rezafungin combined with 7 days of co-trimoxazole for treatment of Pneumocystis pneumonia (PCP) in adults living with human immunodeficiency virus (HIV), which would expand the knowledge of clinical use of rezafungin.”In the company’s words, NCT05835479 on ClinicalTrials.gov
Other names
CD101 · Rezafungin · Intravenous antifungal therapy

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 2Recruiting May 2025 Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
Phase 2Active, not recruiting 30 Nov 2026 Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
Phase 3Completed 29 Jan 2026 Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Phase 1Completed Oct 2015 A Single Ascending Dose Study of CD101 IV in Healthy Subjects
Phase 1Terminated 23 May 2024 Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age
Phase 3/4Authorised not given Rezafungin plasma concentrations in patients with or without extracorporal treatments (ECMO ± RRT)
Phase 4Authorised not given Pharmacokinetic Study of Rezafungin in Patients with Suspected Intra-Abdominal Candidiasis: Peritoneal Diffusion and Candicidal Activity
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Rezafungin Acetate

Following is part of Solo: you see every change to Rezafungin Acetate the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in